Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05985629 · ClinicalTrials.gov registry record · Phase 4
IPACK on Early Pain Scores After ACL Reconstruction
A Phase 4 study of Pain, Postoperative and Anterior Cruciate Ligament Injuries, sponsored by Loyola University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT05985629: Recruiting Phase 4 study of Pain, Postoperative and Anterior Cruciate Ligament Injuries, sponsored by Loyola University.
NCT05985629 is a Phase 4 study of Pain, Postoperative and Anterior Cruciate Ligament Injuries that is actively recruiting participants, run by Loyola University. The registered enrollment target is 78 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05985629, a Phase 4 study of Pain, Postoperative and Anterior Cruciate Ligament Injuries, is actively recruiting participants, sponsored by Loyola University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn whether using an anesthetic technique called IPACK block will control pain after ACL reconstruction surgery. The main questions it aims to answer are: * if participants who receive the IPACK block prior to ACL reconstruction experience less pain after surgery and at 1 day after surgery * if participants who receive the IPACK block prior to ACL reconstruction require less short-term opioid use immediately after surgery and up to one week after surgery. Participants will be randomized 1:1 to 1 of 2 groups: Use of IPACK block during ACL reconstruction vs. placebo (a placebo is a look-alike substance that contains no active drug). Neither the participant nor the investigator will know which group the participants has been assigned to. Researchers will compare self-reported pain scores and short-term opioid use of all study participants.
Conditions Studied
Interventions
- DRUG IPACK
- DRUG PLACEBO
Study Locations (1)
Illinois
- Loyola University Medical Center - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2023-08-03 |
| Est. Completion | 2026-08-03 |
| Phase | Phase 4 |
What NCT05985629 shows while recruiting
NCT05985629 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (71% lower).
The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which IPACK is the first listed.
NCT05985629 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05985629 about?
NCT05985629 is a clinical study titled "IPACK on Early Pain Scores After ACL Reconstruction". The goal of this clinical trial is to learn whether using an anesthetic technique called IPACK block will control pain after ACL reconstruction surgery. The main questions it aims to answer are: * if participants who receive the IPACK block prior to ACL reconstruction experience less pain after sur...
What is the current status of trial NCT05985629?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2023-08-03. Estimated completion is 2026-08-03.
What conditions does trial NCT05985629 study?
This clinical trial studies the following conditions: Pain, Postoperative, Anterior Cruciate Ligament Injuries, Analgesics, Opioid.
What interventions are being tested in trial NCT05985629?
The interventions under investigation include: IPACK (DRUG), PLACEBO (DRUG).
Who is sponsoring clinical trial NCT05985629?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05985629 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05985629's enrollment target sits among peer trials
78 62nd of 113 higher than 51 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI